Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

AIDS

Volumn 13, Issue 6, 1999, Pages 669-676

  Renaud, Marc ^b   Katlama, Christine ^a   Mallet, Alain ^a   Calvez, Vincent ^a   Carcelain, Guislaine ^b   Tubiana, Roland ^a   Jouan, Marc ^a   Caumes, Eric ^a   Agut, Henri ^a   Bricaire, François ^a   Debré, Patrice ^b   Autran, Brigitte ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CHU Pitie Salpêtrière ^*

Author keywords

Antiretroviral drugs; CD4 T cells; HIV; Immune reconstitution; Protease inhibitor

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS;

EID: 0032991490     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199904160-00007     Document Type: Article

References (16)

1. 1. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, et al.: Treatment of human immunodeficiency virus infection with saquinavir zidovudine and Zalcitabine. N Engl J Med 1996, 334:1011-1017.
2. 2. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al.: A controlled trial of two nucleoside analogues plus indinavir in patients with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
3. 3. Gulick RM, Mellors JW, Havlir D, Fron JJ, Gonzalez C, McMahon D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739.
4. 4. Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, et al.: Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997, 349:1443-1445.
5. 5. Palella PJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Salten GA, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
6. 6. Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
7. 7. Kaufmann D, Pantaleo G, Sudre P, Telenti A: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy. Lancet 1998, 351:723-724.
8. 8. Levitz SM: Improvement in CD4 cell counts despite persistently detectable HIV load. N Engl J Med 1998, 338:1074-1075.
9. 9. Piketty C, Castiel P, Belec L, Batisse D, Si Mohamed A, Gilquin J, et al.: Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998, 12:745-750.
10. 10. Phillips AN, Lee CA, Elford J, Janossy G, Timms A, Bofill M, et al.: Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991, 337:389-392.
11. 11. Medley GF, Andernson RM, Cox DR, Billard L: Incubation period of AIDS in patients infected via blood transfusion. Nature 1987, 328:719-721.
12. 12. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, et al.: Age, thymopoiesis, and CD4 T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
13. 13. SAS Institute Inc. SAS/STAT Users Guide, version 6.12. Cary NC: SAS Institute Inc., 1996.
14. 14. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al.: Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
15. 15. Pakker NG, Notermans DW, de Boer RJ, Roos ML, de Wolf F, Hill A, et al.: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med 1998, 4:208-214.
16. 16. Drusano GI, Stein DS: Mathematical modeling of the interrelationship of CD4 lymphocyte count and viral load changes induced by protease inhibitor indinavir. Antimicrob Agents Chemother 1998, 42:358-361.